Dr. Rupak Doshi is the Founder and CEO of OmniSync, a San Diego-based software company whose mission is to help find and fund innovation. Before starting OmniSync, Rupak received a Ph.D. from Cambridge University, conducted postdoctoral research at The Scripps Research Institute and UC San Diego, and worked at the now-publicly-traded biologic drug discovery company, InhibRx. He has also started two other consumer biotech companies in the past, one of which exited within a year and the other found its home within commercial B2C retail. OmniSync’s product suite includes innovative solutions like TurboSBIR – a first-of-its-kind software solution for startups to find and apply for all Federal innovation funding from one place. Through their new product TurboInnovate – a powerful innovation search engine for conducting technical due diligence and market research on innovations, OmniSync’s goal is to help both, innovators and innovation seekers maintain a data-driven pulse on the latest trends across various industries. OmniSync is backed by a number of VCs, angels, as well as the US Air Force.